• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identification of the Receptor for ORAIP That Mediates Cardiac Response to Oxidative Stresses and Development of Treatment

Research Project

Project/Area Number 15390240
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionThe University of Tokyo

Principal Investigator

SEKO Yoshinori  The University of Tokyo, Faculty of Medicine, Lecturer, 医学部附属病院, 講師 (30240708)

Co-Investigator(Kenkyū-buntansha) SHINDO Takayuki  The University of Tokyo, Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (90345215)
久保田 俊一郎  東京大学, 大学院・総合文化研究科, 教授 (00260480)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥13,000,000 (Direct Cost: ¥13,000,000)
Fiscal Year 2004: ¥4,300,000 (Direct Cost: ¥4,300,000)
Fiscal Year 2003: ¥8,700,000 (Direct Cost: ¥8,700,000)
Keywordsoxidative stress / cardiac myocytes / bioactive substance / autocrine / receptor / apoptosis / ischemia / reperfusion / hypoxia / reoxygenation / 酸化ストレス / 心筋細胞 / オートクライン / アポトーシス / MAPK / 生理活性因子 / 受容体
Research Abstract

1.Production of recombinant ORAIP, a bioactive protein that mediates cardiac response to oxidative stresses :
We subcloned a DNA sequence consisting of ORAIP cDNA+FLAG+(6X His) into an expression vector, then transfected the cDNA clone into an appropriate cell line. We purified recombinant ORAIP from the cell lysates with Ni column and an affinity column for FLAG protein.
2.Identification of the ORAIP receptor :
We collected the plasma membrane fraction from cultured cardiac myocyte lysates and solubilized it, then immunoprecipitated ORAIP receptor with recombinant ORAIP. Hypoxia/reoxygenation significantly increased the plasma membrane content of ORAIP receptor within 60 min of reoxygenation. Myocardial ischemia/reperfusion also significantly increased the expression of ORAIP receptor as well as ORAIP on the plasma membrane of cardiac myocytes within 30 min of reperftision.
3.Identification of the cytoprotective factor that mediates cardiac response to oxidative stresses :
We identified cyclophilin A (CyPA) as one of bioactive proteins released from cardiac myocytes in response to oxidative stresses. CyPA activated MAPK family members and Akt as well as increased Bcl-2 in cardiac myocytes. CyPA also increased Bcl-2 and Bcl-XL in cardiac fibroblasts. Taken together, CyPA seems to play a role in cardiac remodeling after ischemia/reperfusion by facilitating the proliferation of cardiac fibroblasts.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (17 results)

All 2004 2003 Other

All Journal Article (13 results) Publications (4 results)

  • [Journal Article] Expression of costimulatory molecules (4-1BBL and Fas) and MHC class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis.2004

    • Author(s)
      Seko Y, Sugishita K, et al.
    • Journal Title

      J Vas Res 41

      Pages: 84-90

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.2004

    • Author(s)
      Seko Y, Fukuda S, Nagai R
    • Journal Title

      Clin Sci 106

      Pages: 439-442

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Hypoxia followed by reoxygenation induces secretion of cyclophilin A (CyPA) from cultured rat cardiac myocytes.2004

    • Author(s)
      Seko Y, Fujimura T, Taka H, et al.
    • Journal Title

      Biochem Biophys Res Commun 317

      Pages: 162-168

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Effect of intravenous heparin on serum levels of endostatin, VEGF and HGF : author's reply.2004

    • Author(s)
      Seko Y
    • Journal Title

      Clin Sci 107

      Pages: 424-424

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Expression of costimulatory molecules (4-1 BBL and Fas) and MHC class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis.2004

    • Author(s)
      Seko Y, Sugishita K, Sato O, et al.
    • Journal Title

      J Vas Res 41

      Pages: 84-90

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Serum levels of endostatin, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.2004

    • Author(s)
      Seko Y, Fukuda S, Nagai R
    • Journal Title

      Clin Sci 106

      Pages: 439-442

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Hypoxia followed by re oxygenation induces secretion of cyclophilin A (CyPA) from cultured rat cardiac myocytes.2004

    • Author(s)
      Seko Y, Fujimura T, Taka H, et al.
    • Journal Title

      Biochem Biophys Res Commun 317

      Pages: 162-168

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Serum levels of endostatin, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy2004

    • Author(s)
      Seko Y, Fukuda S, Nagai R
    • Journal Title

      Clin Sci 106

      Pages: 439-442

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Genetic background influences therapeutic effectiveness of VEGF.2003

    • Author(s)
      Fukino K, Sata M, Seko Y, et al.
    • Journal Title

      Biochem Biophys Res Commun 310

      Pages: 162-168

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Genetic background influences therapeutic effectiveness of VEGF.2003

    • Author(s)
      Fukino K, Sata M, Seko Y, Hirata Y, Nagai R
    • Journal Title

      Biochem Biophys Res Commun 310

      Pages: 143-147

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Takayasu myocarditis mediated by cytotoxic T lymphocytes

    • Author(s)
      Takeda N, Takahashi T, Seko Y, et al.
    • Journal Title

      Internal Med (In press)

    • NAID

      10015567420

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Takayasu myocarditis mediated by cytotoxic T lymphocytes.

    • Author(s)
      Takeda N, Takahashi T, Seko Y, et al.
    • Journal Title

      Intern Med (in press)

    • NAID

      10015567420

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Takayasu myocarditis mediated by cytotoxic T lymphocytes.

    • Author(s)
      Takeda N, Takahashi T, Seko Y, et al.
    • Journal Title

      Internal Med (In press)

    • NAID

      10015567420

    • Related Report
      2004 Annual Research Report
  • [Publications] Fukino K, Sata M, Seko Y, et al.: "Genetic background influences therapeutic effectiveness of VEGF."Biochem Biophys Res Commun. 310. 143-147 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Seko Y, Sugishita K, Sato O, et al.: "Expression of costimulatory molecules (4-1BBL and Fas) and MHC class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis."J Vas Res. 41. 84-90 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Seko Y, Fukuda S, Nagai R: "Serum levels of endostatin, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy."Clin Sci. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Seko Y, Fujimura T, Taka H, et al.: "Hypoxia followed by reoxygenation induces secretion of cyclophilin A (CyPA) from cultured rat cardiac myocytes."Biochem Biophys Res Commun. (in press).

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi